Recombinant SARS-COV-2 Spike RBD (N501Y,K417N,E484K) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02339P-100UG
SARS-COV-2 Spike RBD (N501Y,K417N,E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-COV-2 Spike RBD (N501Y,K417N,E484K) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02339P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant SARS-COV-2 Spike RBD (N501Y,K417N,E484K) Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Arg319-Phe541(N501Y,K417N,E484K). |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | QHD43416.1 |
Target Symbol | Spike RBD (N501Y-K417N-E484K) |
Synonyms | S protein RBD; S glycoprotein RBD; Spike protein RBD |
Species | SARS-COV-2 |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Arg319-Phe541(N501Y,K417N,E484K) |
Mol. Weight | The protein has a predicted MW of 26.2 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized SARS-COV-2 Spike RBD (N501Y,K417N,E484K) , His Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 9.9ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |